$IMMB SWEET EMAILER JUST OUT IMMB Special Update Hot

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

[b]$IMMB SWEET EMAILER JUST OUT >> IMMB Special Update

[/b]

Hot news just came out fron IMMB and guess what, the guy that just was put on the board is a stud ! Also the company mentioned it brought him in as part of the plans to go to NASDAQ. not the exact wording, but here check out today's press and good luck.

$IMMB NASDAQ Uplisting mentioned in PR http://finance.yahoo.com/news/immunotech-labo...00904.html

This type of exposure could be huge in the longterm.

Thomas Hitman Hearns - http://www.youtube.com/watch?v=4c2nwrvTORU&am...e=youtu.be

Sugar Ray Leonad - http://www.youtube.com/watch?v=TqAwgDEDVJ0&am...e=youtu.be

Cory Feldman Link - http://www.youtube.com/watch?v=QyH6tVKBUjg

Cleve Hall Link - http://www.youtube.com/watch?v=ZLcQ12GF0ao

Happy Trading

Video Link  first interview with Bo Linton -   http://www.youtube.com/watch?v=uCjNAf30aeo

Testimonials - www.lifechoicemx.com

Don't be greedy forward this email to a friend.  Can you imagine if everybody sent this email to 5-10 friends how happy your friends would be

A Breakthrough Treatment For HIV, Cancer and Aids Can Make Investors A Nice Profit.

Add Immunotech Laboratories to your watchlist right away.

Ticker IMMB

Hello new and existing subscribers.  Today we are profiling Immunotech Laboratorires ticker IMMB.  The Company produces treatments for patients that have HIV, Aids, Cancer and Hepatitis C.  Please note this is not just some 1 day profile deal here, PSPicks and several others are going to be profiling this for at least a month!

The Float Is About 1,000,000 Shares so this can really fly!

FDA Approval

IMMB just announced an LOI with an International Bio-Tech partner for USA clinical trials.  In other words they are moving towards FDA Approval.  Have you ever seen what happens to a stock after FDA Approval?  Stocks tend to shoot up big time when that happens.  I've seen some companies shoot up for 5000% or higher gains.  Now that would be nice huh?

Company Has Patented Technology

IMMB's  treatments are already patented.   Immunotech (IMMB) appears to be ahead of its competition in many aspects.

Check out the company website immunotechlab.com for detailed information

Treatments And Testimonials Already

When you are making profits trading IMMB you can really feel good about it because they are actually helping to treat these horrible diseases.

Go check out LifeChoiceMX.com right away.  This is a treatment center that is treating patients in Mexico right now with the immunotherapies.  There are actual video tesimonials of people that have been treated and cured.   Were not just talking about a potential treatment, these guys are actually doing it.  The company has also said they are planning on opening centers in Africa and Bulgaria.

Revenues In The Billions

There are 30 Million HIV Patients in Africa alone.  Let alone the rest of the world.  IMMB has indicated that they will be in the Billions in terms of revenues once approved.

Like I said we are going to be covering this one for a while, This is just the start.  Please start your research in these places

Company Website - ImmunotechLab.com

Treatment Center In Mexico - lifechoicemx.comt

Latest Press - http://finance.yahoo.com/news/immunotech-labo...00154.html

More To Come Good Luck !

***********************

Disclaimer

***********************

Notice, by subscribing to our newsletter or browsing our website you agree to the

following terms / conditions.

This marketing report, release, and/or advertisement is a commercial advertisement and

is only to be used for for general information purposes. Never invest in any security

featured on our site, emails, print and videos unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or

joining our email list.

PSPICKS.com, its employees and affiliates are not a Registered Investment Advisors,

Broker Dealers, or a member of any association for other research providers in any jurisdiction whatsoever.

PSPICKS.com is often times compensated to feature certain companies. Payments

typically come from a Third Party holding shares of a Company.  The third parties may

have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. All direct and third party compensation received will be disclosed within each individual email in accordance with section 17(b) of the 1933 Securities Act. Any compensation constitutes a conflict of interest as to our ability

to remain objective in our communication regarding the profiled companies.

Any Compensation for marketing is disclosed at the bottom of this email.

PSPICKS.com has not investigated the background of the third party, the hiring company. Anyone viewing our website and advertisements should assume that the hiring party and affiliates of the hiring party own shares of the profiled company of which they plan to liquidate, further understanding that the liquidation of those shares will most likely impact

the share price of the profiled company negatively. PSPICKS.com affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the share price of the security.

Release of Liability: Through use of this website, and/or ad campaign viewing or using

you agree to hold PSPICKS.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you

may incur. The information contained herein is based on sources that PSPICKS assume

to be reliable, but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. PSPICKS.com encourages readers and investors to supplement the information in these reports with independent research

and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and PSPICKS.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. FURTHERMORE, by accessing, viewing, or using

the website, communications, and advertisements originating from PSPICKS.com you

agree that PSPICKS.com, its owners, officers, directors, contractors, employees, and affiliates are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that PSPICKS.com, its owners, officers, directors, contractors, employees, and affiliates shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to

these sites are provided for your convenience only. PSPICKS.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others

from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold PSPICKS.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website, email, advertisements is at your sole risk. PSPICKS.com disclaims all warranties of any kind, express or implied.

Third Party Web Sites and Information

PSPICKS.com and newsletter may provide hyperlinks to third party websites or access to third party content. PSPICKS.com does not control, endorse, or guarantee content found in such sites. You agree that PSPICKS.com is not responsible for any content, associated

links, resources, or services associated with a third party site. You further agree that PSPICKS.com shall not be liable for any loss or damage of any sort associated with your

use of third party content. Links and access to these sites are provided for your

convenience only None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead PSPICKS.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. PSPICKS.com is compliant with the Can Spam Act of 2003. PSPICKS.com does not offer such advice or analysis, and PSPICKS.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

PSPICKS.com website, emails, and or advertisements may have forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of

risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”,

“estimates”, “believes”, “understands”, or that by statements indicating certain actions

“may”, “could”, or “might” occur. Understand there is no guarantee past performance

will be indicative of future results.

In preparing our publications, PSPICKS.com has relied upon information supplied by its customers, and press releases, which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this

website. Rather, investors should use the information contained in this website as a

starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, PSPICKS.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement.

PSPICKS.com is not responsible for any claims made by the companies advertised herein, nor is PSPICKS.com responsible for any other promotional firm, its program or its structure.

PSPicks expects to be compensated up to $75,000 for marketing services by Third Party.

Immunotech Laboratories Inc (IMMB) Stock Research Links

IMMB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cascades Eyes New Quebec Govt for Growth Partnerships

Updated Category News Views 3

Quebec's New Ministers: A Fresh Start or the Same Old? So the suits in Quebec have shuffled about and Cascades Inc. (TSX: CAS)—a heavyweight in sustainable papermaking—is polishing their best handshake. They're rolling out the welcome mat for the new ministers in the Government of Quebec. As someone who've seen their fair share of this song and dance, the real...

Continue Reading
Sivers Semiconductors Shakes Up Auditors and Incentives

Updated Category News Views 0

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

Continue Reading
Procede Software Acquires RIMSS: Dealer Tech Shift?

Updated Category News Views 3

Procede's Big Play Seems like Procede Software is tossing the dice with its latest move. The software scene for dealership management is as cutthroat as a New York deli lineup, and now we've got Procede moving to scoop up RIMSS. This isn't just a back-office shuffle; it's a world-rocking maneuver that brings decades of dealer technology know-how into one basket. What's...

Continue Reading
Green Builder Media's Fresh Focus on Net Zero Homes

Updated Category News Views 2

There's a fresh breeze blowing through the building industry, and it's got "net zero" written all over it. Green Builder Media is rolling out a pile of new resources aimed at wrangling this beast of a trend. The focus? High-performance, all-electric homes. And they're not just whispering about it—they've got hard data and practical guidance to back up their claims. Net...

Continue Reading
Mercuryo's Swaps: A New Era in Crypto Trading Flexibility

Updated Category News Views 8

Mercuryo's Bold Leap into Crypto Flexibility Mercuryo thinks they've got this crypto game figured out, tossing a curveball into the market with Swaps. It's like they're saying, "Here, make your moves without the usual headaches." Launched on October 22, 2026, this product lets folks trade between 38 digital tokens and struts out 700 possible trading pairs—and that's...

Continue Reading
Labcorp, FDA Collaborate to Tackle Drug Abuse Risks

Updated Category News Views 3

Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...

Continue Reading
Granite Gives Pink Raises $583K for Cancer Research

Updated Category News Views 1

Not Just About Numbers: Employee-Led Push for Health If you've ever doubted the power of collective purpose, take a look at Granite Telecommunications' recent endeavor. This hard-hitting telecom giant, with its robust footprint across North America's communication and tech sectors, isn't resting on its laurels when it comes to social responsibility. Their 'Granite Gives...

Continue Reading
CobbleStone & Chu Chua Tech: A Transformative Alliance

Updated Category News Views 2

Breaking Down the CobbleStone and Chu Chua Collaboration We’re in a tough, interconnected world where tech innovation is racing against the clock. So, when CobbleStone Software raises its hand to join forces with Chu Chua Technology Services LLP, it’s like a shot of adrenaline for anyone invested in North America’s tech wave. Let’s pause and dive right in because...

Continue Reading
QFIN Investors Eye Class Action Amid Regulatory Struggles

Updated Category News Views 2

QFIN Shareholders Unite Amid Regulatory Storm It's not every day you see a stock nosedive by nearly 19% overnight. But when you're investing in a company like Qfin Holdings, you get ready for a wild ride, especially when regulatory changes from China come into play. That's exactly what's happening right now as investors rally around a class action lawsuit against Qfin....

Continue Reading
Bambu Lab Shakes Up 3D Printing with Massive Discounts

Updated Category News Views 5

Price Cuts Bring 3D Printing Mainstream Here's the deal—3D printing used to be the domain of the tech-savvy elite, akin to those early computer geeks holed up in garages. But now? Bambu Lab is throwing open those doors with its Black Friday and Cyber Monday specials, slashing prices like a man on a mission. They're bringing an entire technological leap into our hands,...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSyent Reports Impressive Financial Growth in Recent Quarter

Updated Category News Views 143

BioSyent's Financial Performance Overview BioSyent Inc. has recently announced its financial outcomes for the second quarter (Q2) and the first half (H1) of the year, showing promising growth across all sectors. The company, known for its innovative pharmaceutical products, reported notable increases in sales and profit margins. This positive trend reflects its strong...

Continue Reading
MediCapture Unveils Innovative aiScope™ for Veterinary Applications

Updated Category News Views 108

MediCapture Introduces aiScope™ for Veterinary Training Revolutionizing Medical AI CHEROKEE, Texas — MediCapture Inc., recognized for its prowess in medical imaging technology, has announced the exciting launch of aiScope™. This innovative software operates Vision AI models in real-time, directly on selected MediCapture devices, providing tremendous opportunities in...

Continue Reading
EquipmentShare Faces Class Action Over $77M Misconduct

Updated Category News Views 9

Unpacking the EquipmentShare Fiasco Woah, can't say there aren't fireworks going off at EquipmentShare (NASDAQ:EQPT) these days. Lawsuits piling up like pancakes at a Sunday brunch. And guess what? EquipmentShare's stock took a nosedive, shaking retail investors down to their core. This ain't just any bump in the road—it's messy, sticky, and if you're holding $EQPT,...

Continue Reading
BioCryst Pharmaceuticals Welcomes Babar Ghias as CFO

Updated Category News Views 403

Exciting Leadership Change at BioCryst Pharmaceuticals Today, BioCryst Pharmaceuticals, Inc. has announced a significant addition to its leadership team with the appointment of Babar Ghias as Chief Financial Officer (CFO) and head of corporate development. Mr. Ghias will bring to the role a wealth of experience aimed at driving financial strategy and growth within the...

Continue Reading
MMA Digital Corp.: U.S. Banking Infrastructure Playbook

Updated Category Economy Views 30

Getting banking infrastructure right in the United States is genuinely hard. Not hard in a "read more documentation" way. Hard in a "you won't know what you missed until it bites you six months in" way. The U.S. financial system is layered, fragmented, and built on decades of overlapping regulation. For any company trying to move fast, whether entering the market fresh or...

Continue Reading